UTRF Licensee Veru, Inc. Announces Positive Results of COVID-19 Therapy’s Phase 3 Clinical Study
Veru, Inc. is seeking emergency use authorization for its drug product. The company is scaling up its production of sabizabulin in advance of FDA approval to meet market demand as soon as possible.